How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace
Bacteria are rapidly emerging as a new class of "living medicines" used to kill cancer cells.
Nov 10, 2025
0
11
MeSH tree: C12.900.820.945
Bacteria are rapidly emerging as a new class of "living medicines" used to kill cancer cells.
Nov 10, 2025
0
11
FX-909, a first-in-class investigational oral small molecule inhibitor of peroxisome proliferator-activated receptor gamma (PPARG), showed early signs of clinical benefit in patients with advanced urothelial carcinoma, according ...
Oct 22, 2025
0
9
Bladder cancer is one of the most common cancers worldwide. Men are around four times more likely to develop it than women, and smoking is the main known environmental risk factor. However, the biological mechanisms behind ...
Oct 8, 2025
0
19
The bladder is easy to overlook—until it starts causing trouble. This small, balloon-like organ in the lower urinary tract quietly stores and releases urine, helping the body eliminate waste and maintain fluid balance.
Oct 6, 2025
0
16
Researchers from the University of Birmingham's Bladder Cancer Research Center have used a new method to detect chemical changes in the DNA in an individual's urine sample; epigenetic changes, called methylation.
Sep 17, 2025
0
13
The U.S. Food and Drug Administration has approved Inlexzo (gemcitabine intravesical system) for the treatment of patients with certain types of bladder cancer.
Sep 11, 2025
0
19
Bladder cancer is a painful and often recurring disease, not just for humans, but for our canine companions as well. Urothelial carcinoma, the most common type of bladder cancer, affects both species in remarkably similar ...
Chemotherapy used to target and kill bladder cancer cells may trigger an inflammatory response that ultimately may make the cancer more resistant to treatment, according to new research from scientists at Houston Methodist.
Jul 16, 2025
0
17
More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat early-stage bladder cancer.
May 29, 2025
0
29
A new, error-corrected method for detecting cancer from blood samples is much more sensitive and accurate than prior methods and may be useful for monitoring disease status in patients following treatment, according to a ...
Apr 12, 2025
0
74